
Hai Yi
Articles
-
Jan 9, 2025 |
onlinelibrary.wiley.com | Ying He |Yan Deng |Hai Yi
Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of UseUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.
-
Nov 24, 2024 |
nature.com | Xiao-bing Huang |Yi Luo |Yu-Hua Li |Xi Zhang |Hai Yi |Xiang-Yu Zhao | +2 more
AbstractChronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, allo-HSCT is not appropriate for all CMML patients, and relapse is the leading cause of treatment failure. This project conducted a nationwide multicenter real-world study to develop a novel prediction scoring system for early relapse.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →